Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | G6PD | P11413 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.32 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.31 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17807717 | 0.86 | MEN1 (0.33) | OPRD1MEN1KMT2AL3MBTL1 | |
| SCHEMBL17072579 | 0.82 | PDK2 (0.36) | — | |
| SCHEMBL16158459 | 0.75 | — | — | |
| SCHEMBL18010260 | 0.71 | — | — | |
| SCHEMBL13750191 | 0.70 | — | — | |
| SCHEMBL17883213 | 0.70 | PDK2 (0.42) | MEN1KMT2AL3MBTL1APP | |
| SCHEMBL13816235 | 0.65 | — | — | |
| SCHEMBL26306924 | 0.64 | CYP26A1 (0.47) | OPRD1HPGDMEN1GAAG6PD | |
| SCHEMBL20123114 | 0.64 | OPRM1 (0.33) | OPRD1HPGDMEN1KMT2AL3MBTL1 | |
| SCHEMBL3373557 | 0.63 | GAA (0.67) | HPGDMEN1GAAG6PDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150255720-A1 | Compounds for Electronic Devices | MERCK PATENT GMBH (DE) | 2015-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150255720-A1 | Compounds for Electronic Devices | DDT, EED, VDAC2 | OPRD1 1553/4885HPGD 1070/4885MEN1 1474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.